Charlotte Ramon

ORCID: 0000-0003-2504-5232
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Immunodeficiency and Autoimmune Disorders
  • Transplantation: Methods and Outcomes
  • RNA modifications and cancer
  • Mitochondrial Function and Pathology
  • Microbial Metabolic Engineering and Bioproduction
  • Metabolism and Genetic Disorders
  • Bioinformatics and Genomic Networks
  • Metabolomics and Mass Spectrometry Studies
  • High Altitude and Hypoxia
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Biosensors and Analytical Detection
  • Microfluidic and Capillary Electrophoresis Applications
  • Digestive system and related health
  • Organ Transplantation Techniques and Outcomes
  • Renal Transplantation Outcomes and Treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Hydrogen's biological and therapeutic effects
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Microscopic Colitis
  • Obstructive Sleep Apnea Research
  • Gut microbiota and health
  • Gene Regulatory Network Analysis
  • Celiac Disease Research and Management
  • Mycobacterium research and diagnosis

University of Pittsburgh
2024

ETH Zurich
2018-2023

SIB Swiss Institute of Bioinformatics
2018-2023

University of Pennsylvania
2021

Life Science Zurich
2018

IBM Research - Zurich
2017

Eva Serra Tobias Schwerd Loukas Moutsianas Athena Cavounidis Laura Fachal and 95 more Sumeet Pandey Jochen Kammermeier Nicholas M. Croft Carsten Posovszky Astor Rodrigues Richard K. Russell Farah M. Barakat Marcus Auth Robert Heuschkel Matthias Zilbauer Krzysztof Fyderek Christian Braegger Simon Travis Jack Satsangi Miles Parkes Nikhil Thapar Helen Ferry Julie C. Matte Kimberly Gilmour Andrzej Wędrychowicz Peter Sullivan Carmel Moore Jennifer Sambrook Willem H. Ouwehand David J. Roberts John Danesh Toni A. Baeumler Tudor A. Fulga Eli M. Carrami Ahmed A. Ahmed Rachel Wilson Jeffrey C. Barrett Abdul Elkadri Anne M. Griffiths Marlen Zurek Caterina Strisciuglio Mamoun Elawad Bernice Lo Carolina V. Arancibia-Cárcamo Adam Bailey Eleanor Barnes Elizabeth Bird‐Lieberman Oliver Brain Barbara Braden Jane Collier James E. East Lucy Howarth Satish Keshav Paul Klenerman Simon J. Leedham Rebecca Palmer Fiona Powrie Alison Simmons Matthew R. Walker Zoe Tolkien Stephen Kaptoge David L. Allen Susan Mehenny Jonathan Mant Emanuele Di Angelantonio Simon G. Thompson Bahtiyar Yılmaz Pascal Juillerat Markus B. Geuking Reiner Wiest Andrew J. Macpherson Francisco Bravo Lukas Brügger Ove Carstens Ulrike Graf Bigler Benjamin Heimgartner Monica Rusticeanu Sybille Schmid Bruno Strebel Aurora Tatu Radu Țuțuian Reiner Wiest Ove Øyås Charlotte Ramon Jörg Stelling Yannick Franc Nicolas Fournier Valérie Pittet Bernard Burnand Mara Egger Yannick Franc Delphine Golay Astrid Marot Leilla Musso Valérie Pittet Jean‐Benoît Rossel Vivianne Seematter Joachim R. Sommer Rachel Vulliamy Pierre Michetti

Abstract Very-early-onset inflammatory bowel disease (VEO-IBD) is a heterogeneous phenotype associated with spectrum of rare Mendelian disorders. Here, we perform whole-exome-sequencing and genome-wide genotyping in 145 patients (median age-at-diagnosis 3.5 years), whom no disorders were clinically suspected. In five detect primary immunodeficiency or enteropathy, clinical consequences ( XIAP, CYBA, SH2D1A, PCSK1 ). We also present case study VEO-IBD patient mosaic de novo, pathogenic allele...

10.1038/s41467-019-14275-y article EN cc-by Nature Communications 2020-02-21

Abstract Metabolic phenotypes are pivotal for many areas, but disentangling how evolutionary history and environmental adaptation shape these is an open problem. Especially microbes, which metabolically diverse often interact in complex communities, few can be determined directly. Instead, potential commonly inferred from genomic information, rarely were model-predicted employed beyond the species level. Here, we propose sensitivity correlations to quantify similarity of predicted metabolic...

10.1038/s41467-023-37429-5 article EN cc-by Nature Communications 2023-03-27

Methylmalonyl-coenzyme A (CoA) mutase (MMUT)-type methylmalonic aciduria is a rare inherited metabolic disease caused by the loss of function MMUT enzyme. Patients develop symptoms resembling those primary mitochondrial disorders, but underlying causes dysfunction remain unclear. Here, we examined environmental and genetic interactions in deficiency using combination computational modeling cellular models to decipher pathways interacting with MMUT. Immortalized fibroblast (hTERT BJ5ta)...

10.1002/jimd.12575 article EN cc-by-nc Journal of Inherited Metabolic Disease 2022-11-13

The use of microfluidic technology represents a strong opportunity for providing sensitive, low-cost and rapid diagnosis at the point-of-care such might therefore support better, faster more efficient treatment patients home in healthcare settings both developed developing countries. In this work, we consider luminescence-based assays as an alternative to well-established fluorescence-based systems because luminescence does not require light source or expensive optical components is...

10.1117/12.2250765 article EN Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE 2017-02-28

Abstract MMUT-type methylmalonic aciduria is a rare inherited metabolic disease caused by the loss of function methylmalonyl-CoA mutase (MMUT) enzyme. Patients develop symptoms resembling those primary mitochondrial disorders, but underlying causes dysfunction remain unclear. Here, we examined environmental and genetic interactions in MMUT deficiency using combination computational modeling cellular models to decipher pathways interacting with MMUT. Immortalized fibroblast (hTERT BJ5ta)...

10.1101/2022.08.10.503435 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2022-08-12
Coming Soon ...